{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:23:35Z","timestamp":1751275415456},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/beha.2001.0143","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T07:24:48Z","timestamp":1027668288000},"page":"455-462","source":"Crossref","is-referenced-by-count":20,"title":["Management of inherited von Willebrand disease"],"prefix":"10.1053","volume":"14","author":[{"given":"Pier Mannuccio","family":"Mannucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto B.","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0143_RF1","series-title":"Thrombosis and Hemorrhage","first-page":"305","article-title":"von Willebrand factor","author":"Ruggeri","year":"1993"},{"key":"10.1053\/beha.2001.0143_RF2","series-title":"Haemostasis and Thrombosis","first-page":"843","article-title":"von Willebrand disease","author":"Sadler","year":"1993"},{"key":"10.1053\/beha.2001.0143_RF3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0143_RF4","first-page":"363","article-title":"The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, ATIII and OT in man","volume":"27","author":"Cash","year":"1974","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0143_RF5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jcp.1041540307","article-title":"Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells","volume":"154","author":"Hashemi","year":"1993","journal-title":"Journal of Cell Physiology"},{"key":"10.1053\/beha.2001.0143_RF6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","article-title":"A new pharmacological approach to the management of hemophilia and von Willebrand disease","volume":"1","author":"Mannucci","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0143_RF7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0268-960X(91)90032-8","article-title":"Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease","volume":"5","author":"Rodeghiero","year":"1991","journal-title":"Blood Reviews"},{"key":"10.1053\/beha.2001.0143_RF8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1992.tb04598.x","article-title":"Consistency of responses to repeated DDAVP infusions in patients with von Willebrand disease and haemophilia A","volume":"82","author":"Mannucci","year":"1992","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0143_RF9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830310310","article-title":"Hyponatremia and seizures in young children given DDAVP","volume":"31","author":"Smith","year":"1989","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0143_RF10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJM198801143180215","article-title":"Myocardial infarction in a patient with hemophilia A treated with DDAVP","volume":"318","author":"Bond","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0143_RF11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830280115","article-title":"Thrombosis following desmopressin for uremic bleeding","volume":"28","author":"Byrnes","year":"1988","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0143_RF12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor","volume":"66","author":"Mannucci","year":"1985","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0143_RF13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type II B von Willebrand disease","volume":"309","author":"Holmberg","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0143_RF14","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V74.5.1859.1859","article-title":"DDAVP for type IIB von Willebrand disease","volume":"74","author":"Fowler","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0143_RF15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0609.1990.tb00412.x","article-title":"Platelet aggregation and pseudothrombocytopenia induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type II B von Willebrand disease","volume":"45","author":"Casonato","year":"1990","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2001.0143_RF16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","article-title":"Biological effect of desmopressin in eight patients with type 2 N (\u2018Normandy\u2019) von Willebrand disease","volume":"88","author":"Mazurier","year":"1994","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0143_RF17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1995.tb08921.x","article-title":"Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease","volume":"89","author":"Castaman","year":"1995","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0143_RF18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V30.3.375.375","article-title":"Correction of the hemostatic defects in von Willebrand disease","volume":"30","author":"Perkins","year":"1967","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0143_RF19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1423-0410.1992.tb01198.x","article-title":"Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease","volume":"62","author":"Rodeghiero","year":"1992","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2001.0143_RF20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.1992.tb01159.x","article-title":"Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate","volume":"62","author":"Burnouf-Radosevich","year":"1992","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2001.0143_RF21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00001721-199304060-00018","article-title":"Biological effects of a S\/D-treated, very high purity, von Willebrand factor concentrate in five patients with severe von Willebrand disease","volume":"4","author":"Meriane","year":"1993","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1053\/beha.2001.0143_RF22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1963.tb05457.x","article-title":"Transfusion studies in von Willebrand disease: effect on bleeding time and factor VIII","volume":"9","author":"Cornu","year":"1963","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0143_RF23","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V83.10.3018.3018","article-title":"Proteolysis of von Willebrand factor in therapeutic plasma concentrates","volume":"83","author":"Mannucci","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0143_RF24","first-page":"559","article-title":"A high purity factor VIII concentrate in the treatment of von Willebrand\u2019s disease","author":"Mannucci","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0143_RF25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V74.6.1972.1972","article-title":"DDAVP shortens the prolonged bleeding time of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor","volume":"74","author":"Cattaneo","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0143_RF26","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood.V77.9.1901.1901","article-title":"Hemostatic effect of normal platelet transfusion in severe von Willebrand disease","volume":"77","author":"Castillo","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0143_RF27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1537-2995.1997.37897424399.x","article-title":"Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect","volume":"37","author":"Castillo","year":"1987","journal-title":"Transfusion"},{"key":"10.1053\/beha.2001.0143_RF28","first-page":"282","article-title":"Pregnancy in women with different types of von Willebrand disease","volume":"68","author":"Conti","year":"1986","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beha.2001.0143_RF29","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V69.3.786.786","article-title":"Thrombocytopenia associated with pregnancy in a patient with type II B vWD","volume":"69","author":"Rick","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0143_RF30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.1990.tb02621.x","article-title":"Spontaneous platelet aggregation during pregnancy in a patient with vWD type II B can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb\/IIIa","volume":"75","author":"Pareti","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0143_RF31","series-title":"Inhibitors to Coagulation Factors","first-page":"87","article-title":"Antibodies to von Willebrand factor in von Willebrand disease","author":"Mannucci","year":"1995"},{"key":"10.1053\/beha.2001.0143_RF32","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI112974","article-title":"Gene deletion correlates with the development of alloantibodies in von Willebrand disease","volume":"79","author":"Shelton-Inloes","year":"1987","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0143_RF33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V57.1.25.25","article-title":"Precipitating antibodies to FVIII\/von Willebrand factor in von Willebrand disease: effects on replacement therapy","volume":"57","author":"Mannucci","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0143_RF34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-0609.1987.tb01458.x","article-title":"Life-threatening reaction to FVIII concentrate in a patient with severe vWD and alloantibodies to von Willebrand factor","volume":"39","author":"Mannucci","year":"1987","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2001.0143_RF35","first-page":"348","article-title":"Posttransfusion anaphylactic reaction in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor","volume":"125","author":"Bergamaschini","year":"1995","journal-title":"Journal of Laboratory and Clinical Medicine"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T16:29:32Z","timestamp":1581006572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521692601901434"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0143","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}